Trials / Withdrawn
WithdrawnNCT06719531
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Medtronic MiniMed, Inc. · Industry
- Sex
- All
- Age
- 11 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes. This study will test the performance of the study sensor(s) for 7-14 days of wear in patients who are 11-80 years old with type 1 or type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous Glucose Monitoring | CGM and frequent sample testing |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2024-12-06
- Last updated
- 2025-06-03
Locations
28 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06719531. Inclusion in this directory is not an endorsement.